Westpac Banking Corp Has $6.07 Million Holdings in Metlife Inc (MET)

Westpac Banking Corp lowered its stake in shares of Metlife Inc (NYSE:MET) by 5.1% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 120,035 shares of the financial services provider’s stock after selling 6,433 shares during the period. Westpac Banking Corp’s holdings in Metlife were worth $6,069,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors also recently bought and sold shares of MET. Beach Investment Management LLC. purchased a new stake in Metlife during the second quarter worth $1,471,000. HPM Partners LLC lifted its holdings in shares of Metlife by 2.9% during the 2nd quarter. HPM Partners LLC now owns 32,742 shares of the financial services provider’s stock valued at $1,799,000 after purchasing an additional 915 shares during the last quarter. AMG Funds LLC lifted its holdings in shares of Metlife by 0.7% during the 2nd quarter. AMG Funds LLC now owns 31,352 shares of the financial services provider’s stock valued at $1,722,000 after purchasing an additional 220 shares during the last quarter. Bfsg LLC purchased a new stake in shares of Metlife during the 2nd quarter valued at $237,000. Finally, Dai Ichi Life Insurance Company Ltd lifted its holdings in shares of Metlife by 49.1% during the 2nd quarter. Dai Ichi Life Insurance Company Ltd now owns 140,168 shares of the financial services provider’s stock valued at $7,701,000 after purchasing an additional 46,175 shares during the last quarter. Institutional investors own 76.27% of the company’s stock.

Metlife Inc (NYSE MET) opened at $53.40 on Friday. The company has a debt-to-equity ratio of 0.31, a current ratio of 0.16 and a quick ratio of 0.16. Metlife Inc has a 12-month low of $44.43 and a 12-month high of $55.91. The stock has a market capitalization of $56,192.77, a price-to-earnings ratio of -106.80, a P/E/G ratio of 1.19 and a beta of 1.49.

Metlife (NYSE:MET) last released its earnings results on Wednesday, November 1st. The financial services provider reported $1.09 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.90 by $0.19. Metlife had a positive return on equity of 8.81% and a negative net margin of 0.75%. The firm had revenue of $16.10 billion for the quarter, compared to the consensus estimate of $15.47 billion. During the same period in the prior year, the firm earned $1.28 EPS. The firm’s revenue was up 1.7% on a year-over-year basis. research analysts predict that Metlife Inc will post 4.42 earnings per share for the current year.

The company also recently announced a quarterly dividend, which will be paid on Tuesday, March 13th. Investors of record on Monday, February 5th will be given a $0.40 dividend. This represents a $1.60 annualized dividend and a dividend yield of 3.00%. The ex-dividend date of this dividend is Friday, February 2nd. Metlife’s payout ratio is -320.00%.

In related news, insider Christopher G. Townsend sold 55,712 shares of the company’s stock in a transaction on Monday, November 6th. The stock was sold at an average price of $54.29, for a total value of $3,024,604.48. Following the transaction, the insider now directly owns 25,181 shares of the company’s stock, valued at approximately $1,367,076.49. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, insider Christopher G. Townsend sold 82,731 shares of the company’s stock in a transaction on Friday, November 3rd. The shares were sold at an average price of $54.60, for a total value of $4,517,112.60. Following the completion of the transaction, the insider now directly owns 49,660 shares in the company, valued at $2,711,436. The disclosure for this sale can be found here. 0.32% of the stock is owned by corporate insiders.

Several analysts have recently commented on MET shares. Goldman Sachs Group started coverage on Metlife in a report on Wednesday, October 18th. They set a “conviction-buy” rating and a $61.00 price objective for the company. ValuEngine lowered Metlife from a “strong-buy” rating to a “buy” rating in a report on Thursday, November 9th. Zacks Investment Research lowered Metlife from a “hold” rating to a “sell” rating in a report on Tuesday, January 2nd. Royal Bank of Canada reiterated an “outperform” rating and set a $60.00 price objective (up previously from $56.00) on shares of Metlife in a report on Friday, November 3rd. Finally, TheStreet upgraded Metlife from a “c+” rating to a “b” rating in a report on Wednesday, October 4th. One equities research analyst has rated the stock with a sell rating, ten have assigned a hold rating, nine have issued a buy rating and one has assigned a strong buy rating to the company. Metlife currently has an average rating of “Hold” and an average target price of $57.77.

WARNING: This story was first posted by TrueBlueTribune and is the property of of TrueBlueTribune. If you are accessing this story on another publication, it was copied illegally and reposted in violation of international copyright laws. The legal version of this story can be viewed at https://www.truebluetribune.com/2018/01/21/westpac-banking-corp-has-6-07-million-holdings-in-metlife-inc-met.html.

Metlife Company Profile

MetLife, Inc is a provider of life insurance, annuities, employee benefits and asset management. The Company’s segments include U.S.; Asia; Latin America; Europe, the Middle East and Africa (EMEA); MetLife Holdings, and Corporate & Other. Its U.S. segment is organized into Group Benefits, Retirement and Income Solutions and Property & Casualty businesses.

Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Metlife Inc (NYSE:MET).

Institutional Ownership by Quarter for Metlife (NYSE:MET)

Receive News & Ratings for Metlife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Metlife and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply